Clinical-stage biopharma

Zenas BioPharma Showcases Autoimmune Advances at Q4 2025 Events

Dateline — WALTHAM, Mass., November 11, 2025:Zenas BioPharma, Inc. (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company dedicated to developing...

By cGxPwire Editor
November 12, 2025

Bio-Pharma

LB Pharmaceuticals to Present Key Data at Stifel 2025

NEW YORK, November 6, 2025 — LB Pharmaceuticals Inc. (NASDAQ: LBRX), a clinical-stage biopharmaceutical company focused on developing therapies...

By cGxPwire Editor
November 6, 2025

.Clinical MedTech

Pulse Biosciences Secures FDA IDE Approval to Launch Clinical Trial of nsPFA Cardiac Surgery System for Atrial Fibrillation

Hayward, CA – September 9, 2025 – Pulse Biosciences, a pioneer in bioelectric medicine and nanosecond pulsed field ablation...

By cGxPwire Editor
September 9, 2025

Bio-Pharma M&A

Novartis to Acquire Tourmaline Bio, Expanding ASCVD Pipeline

September 9, 2025 – Basel – In a move set to strengthen its cardiovascular disease portfolio, Novartis announced an...

By cGxPwire Editor
September 9, 2025

We work Hard to get you posted with latest updates

Unwrap our new Directory

Clinical-stage biopharma

Zenas BioPharma Showcases Autoimmune Advances at Q4 2025 Events

LB Pharmaceuticals to Present Key Data at Stifel 2025

Pulse Biosciences Secures FDA IDE Approval to Launch Clinical Trial of nsPFA Cardiac Surgery System for Atrial Fibrillation

Novartis to Acquire Tourmaline Bio, Expanding ASCVD Pipeline